Select Page
Responsive Centered YouTube Video
Insights from the pioneer of mRNA technology on his background, career, and experiences in the field
  • Reflecting on his career, experiences, and thoughts on the Nobel Prize in the field of mRNA technology. 0:08

  • Worked on biod defense products and vaccines, interacting with individuals from the ‘deep State’ and CIA connections. 1:45

  • Significant impact on the scientific community with his insights and perspectives on mRNA technology. 1:54

  • Robert Malone’s diverse educational background and extensive experience in gene therapy and vaccine development. 3:16

  • Living a simple life on a horse farm in Northern Virginia with his wife, Dr. Joelglasp Malone. 3:26

  • Background in pathology, virology, immunology, and molecular biology, with a focus on HIV and gene transfer research. 4:00

  • Contributions to the field of gene delivery using pulse electrical fields and founding a company based on this technology. 5:25

  • His involvement in various research projects and collaborations with organizations like the US Army and Gates Foundation. 6:39

In-depth background on mRNA technology development and patent issues
  • Speaker’s involvement in bringing forward vaccine candidates 7:40

  • Experience in advancing bio defense products and outbreak response 8:23

  • Transition from Sulk Institute to Vical for mRNA research 10:37

  • Patent issues and conflicts with mentor at Sulk Institute 11:05

  • Discovery of naked DNA and RNA delivery at Vical 11:15

  • Details on patent filings and abandonment by Sulk Institute 11:55

  • Innovations in lipid formulations for mRNA delivery 13:02

  • Challenges faced in the early stages of mRNA technology development 13:24

Challenges and ethical decisions in mRNA technology development leading to career transitions
  • Challenges faced in developing gene therapy for Cystic Fibrosis 15:02

  • Struggles with funding and rejection due to perceived delivery problem solved by another entity 16:35

  • Experience as a whistleblower regarding unethical practices in academia 18:05

  • Importance of maintaining good relationships and support from colleagues during career setbacks 19:08

  • Personal growth and sense of security from standing by moral principles despite consequences 20:08

Personal journey of overcoming trauma, gaslighting, and backlash while standing up for recognition of contributions
  • Overcoming trauma and PTSD diagnosis to speak out with support from spouse 20:25

  • Encouragement from spouse to share experiences despite past strategy of staying quiet 20:45

  • Triggered to stand up against erasure of contributions, leading to backlash from media and academia 22:33

  • Facing backlash and misrepresentation from various media outlets and academic institutions 25:01

  • Focus on patents over publications leading to weaponization of achievements 26:12

  • Reflecting on the impact of staying silent versus speaking out against injustice 26:37

Insights on the recent Nobel Prize decision regarding mRNA vaccine technology
  • Discussion on the therapeutic value of sharing traumatic experiences 27:03

  • Impact of not being credited for work on mRNA technology 28:46

  • Consequences faced by individuals for speaking against mainstream narratives 29:06

  • Surprise and disappointment over Nobel Prize decision 30:23

  • Committee’s unusual carveout for award related to mRNA vaccines against Co 19 32:01

  • Vindication in the fact that award was not for invention of mRNA technology 33:00

Controversies surrounding the Nobel Prize for mRNA technology originator and its implications
  • Committee’s false assertions about mRNA technology origin and vaccine development 33:27

  • Nobel Prize justification based on questionable claims and political influence 33:38

  • Misleading statements in press releases regarding vaccine efficacy and development process 35:03

  • Use of modified base in mRNA vaccines not the primary reason for rapid development 36:08

  • Emotional impact of social media attacks following the Nobel Prize announcement 38:01

  • Recognition received by others involved in mRNA technology research 40:04

Insights on the impact of mRNA technology on public health and the biomedical industry
  • Science is a challenging field with continuous discoveries and setbacks. 40:28

  • Emotional resilience required to navigate challenges in public health and technology development. 41:20

  • Concerns about the misuse of technology and its impact on public trust in health institutions. 43:05

  • Critique of emergency use authorization and its consequences on global competitiveness in biopharmaceuticals. 44:04

  • Contradictions in initial virus severity claims and their role in shaping public health responses. 46:10

  • Acknowledgment of ethical breaches in product development and the need for adherence to international norms. 47:09

Challenges and risks associated with mRNA technology and lipid nanoparticle delivery systems
  • Regulatory uncertainty in pharmaceutical development space 47:24

  • Unpredictability in FDA standards and approval processes 47:36

  • Concerns about compromised integrity of the system 48:19

  • Risks associated with lipid nanoparticle delivery system 48:35

  • Data showing high adverse event rate at certain dosage levels 49:38

  • Importance of lipid formulation technology in mRNA development 51:00

  • Demonstration of effectiveness without Pseudo iDine in formulations 52:22

  • Immunosuppressive characteristics and risks of mRNA molecules 52:44

Insights on mRNA vaccine toxicity and scientific community's response
  • mRNA vaccines share common toxicities like cardiotoxicity and coagulopathy. 54:00

  • The formulation of mRNA vaccines may contribute to toxicities. 55:09

  • Complex interaction of lipid particles, mRNA, and spike protein leads to toxicity. 55:34

  • Questioning why scientific community overlooks potential issues with mRNA vaccines. 56:11

  • The speaker is puzzled by the ideological perspective surrounding mRNA vaccines. 56:20

  • A reminder that understanding others’ perspectives is challenging. 57:10